Jim Cramer’s Recent Thoughts on These 8 Stocks

5. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 67

Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer recently shared thoughts on. Cramer showed his disappointment in the company’s schizophrenia medicine sales, as he commented:

“Look, I, my Charitable Trust owns Bristol, looks like a mistake because I, I believed in Cobenfy, which is a, a pretty good product, but it’s not selling well at all.”

Bristol-Myers Squibb Company (NYSE:BMY) develops biopharmaceutical products for cancer, cardiovascular, autoimmune, and neurological diseases. During the September 26 episode, when a caller asked if they should add to their position in the company’s stock, Cramer replied:

“Well… I have said, and I’ve been abject about it, that I think I might be wrong in Bristol. That’s why I’ve not added to it. J&J is doing a better job than Bristol, and it’s rankling me. Let’s listen to J&J. We’re not afraid to take a loss if we have to, but we’re not giving up yet.”